The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 34, Issue 1, Pages 117-123
Publisher
Informa UK Limited
Online
2018-10-26
DOI
10.1080/14756366.2018.1532419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK
- (2018) Tanja Davis et al. BIOCHEMICAL PHARMACOLOGY
- Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
- (2018) Carrie J. Lovitt et al. BMC CANCER
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX
- (2018) Murat Bozdag et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
- (2018) Claudiu T. Supuran et al. MEDICINAL RESEARCH REVIEWS
- The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
- (2017) Dimakatso Alice Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis
- (2017) Elena Andreucci et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation
- (2017) Jianming He et al. Journal of Cancer
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Metastatic melanoma treatment: Combining old and new therapies
- (2016) Ryan J. Davey et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma
- (2016) Kulthida Vaeteewoottacharn et al. TUMOR BIOLOGY
- The role of tumor microenvironment in therapeutic resistance
- (2016) Beomseok Son et al. Oncotarget
- Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression
- (2016) Terumasa Sowa et al. Cancer Medicine
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- (2016) Simon J. A. van Kuijk et al. Frontiers in Oncology
- Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
- (2015) Paul C. McDonald et al. Oncotarget
- Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy
- (2014) Silvia Peppicelli et al. CANCER AND METASTASIS REVIEWS
- Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: A new concept of dual targeting drugs
- (2013) Ludwig Dubois et al. RADIOTHERAPY AND ONCOLOGY
- Challenging resistance mechanisms to therapies for metastatic melanoma
- (2013) Lucio Tentori et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
- (2011) Y. Lou et al. CANCER RESEARCH
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- Carbonic anhydrase inhibitors
- (2010) Claudiu T. Supuran BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
- (2010) M İlie et al. BRITISH JOURNAL OF CANCER
- 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency
- (2010) K Bracht et al. BRITISH JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now